Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: INTRON BIOTECHNOLOGY, INC.
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-09-15 to 2024-09-14
Current total value of award: $138600.63
Description: ARMY RESEARCH AND DEVELOPMENT-UPEC-TARGETING PHAGE ANTIMICROBIALS 2